Cancer Pharmacology Lab under the spotlight at the 2017 International Symposium on Malignant Mesothelioma

Bethesda,
We were extremely pleased to participate to this important meeting where mesothelioma patients, scientists, caregivers, family members, bereaved, and medical professionals came together for conference sessions, socialization, award presentations, and advocacy.
The research of our group has been awarded with two poster prizes at the International Symposium on Malignant Mesothelioma on March 27-29, 2017 in Bethesda, MD, US.
The good news on these awards and the picture with Dr. Alice Guazzelli (Phd at Salford University, with Prof. Mutti) were reported on the website of the “Gruppo Italiano Mesotelioma”
www.gime.it/congresso-marf-a-whashington

Moreover, the main findings presented by Dr. Giovannetti (see picture) “Interplay of hypoxia and proton-coupled folate transporter in pemetrexed-resistance of malignant pleural mesothelioma (MPM): clinical evidence and new pharmacological strategies” have been then published on Annals of Oncology:
www.ncbi.nlm.nih.gov/pubmed/28945836